Advanced search
Publication Cover
Journal of Environmental Science and Health, Part A
Toxic/Hazardous Substances and Environmental Engineering
Volume 57, 2022 - Issue 8
Submit an article Journal homepage
291
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Ozonation and UV photolysis for removing anticancer drug residues from hospital wastewater

Darliana Mello SouzaChemistry Department, Federal University of Santa Maria, Santa Maria, RS, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8434-5318
ORCID Icon,
Jaqueline Fabiane ReichertChemistry Department, Federal University of Santa Maria, Santa Maria, RS, Brazil
,
Vanessa Ramos do NascimentoChemistry Department, Federal University of Santa Maria, Santa Maria, RS, Brazil
&
Ayrton Figueiredo MartinsChemistry Department, Federal University of Santa Maria, Santa Maria, RS, Brazil
Pages 635-644 | Received 24 Nov 2021, Accepted 22 Jun 2022, Published online: 18 Jul 2022

References

  • Botero-Coy, A. M.; Martínez-Pachón, D.; Boix, C.; Rincón, R. J.; Castillo, N.; Arias-Marín, L. P.; Manrique-Losada, L.; Torres-Palma, R.; Moncayo-Lasso, A.; Hernández, F. An Investigation into the Occurrence and Removal of Pharmaceuticals in Colombian Wastewater. Sci. Total Environ. 2018, 642, 842–853. DOI: 10.1016/j.scitotenv.2018.06.088.
  • Reichert, J. F.; Souza, D. M.; Martins, A. F. Antipsychotic Drugs in Hospital Wastewater and a Preliminary Risk Assessment. Ecotoxicol. Environ. Saf. 2019, 170, 559–567. DOI: 10.1016/j.ecoenv.2018.12.021.
  • Cristóvão, M. B.; Bento-Silva, A.; Bronze, M. R.; Crespo, J. G.; Pereira, V. J. Detection of Anticancer Drugs in Wastewater Effluents: Grab versus Passive Sampling. Sci. Total Environ. 2021, 786, 147477. DOI: 10.1016/j.scitotenv.2021.147477.
  • Seben, D.; Toebe, M.; Wastowski, A. D.; Hofstätter, K.; Volpatto, F.; Zanella, R.; Prestes, O. D.; Golombieski, J. I. Water Quality Variables and Emerging Environmental Contaminant in Water for Human Consumption in Rio Grande Do Sul, Brazil. Environ. Challenge. 2021, 5, 100266. DOI: 10.1016/j.envc.2021.100266.
  • Patel, M.; Kumar, R.; Kishor, K.; Mlsna, T.; Pittman, C. U.; Mohan, D. Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods. Chem Rev. 2019, 119, 3510–3673.
  • Biswas, P.; Vellanki, B. P.; Kazmi, A. A. Investigating a Broad Range of Emerging Contaminants in a Set of Anthropogenically Impacted Environmental Compartments. Sci. Total Environ. 2022, 824, 153757. DOI: 10.1016/j.scitotenv.2022.153757.
  • Della-Flora, A.; Wilde, M. L.; Thue, P. S.; Lima, D.; Lima, E. C.; Sirtori, C. Combination of Solar photo-Fenton and Adsorption Process for Removal of the Anticancer Drug Flutamide and Its Transformation Products from Hospital Wastewater. J. Hazard. Mater. 2020, 396, 122699. DOI: 10.1016/j.jhazmat.2020.122699.
  • Rowney, N. C.; Johnson, A. C.; Williams, R. J. Cytotoxic Drugs in Drinking Water: A Prediction and Risk Assessment Exercise for the Thames Catchment in the United Kingdom. Environ. Toxicol. Chem. 2009, 28, 2733–2743. DOI: 10.1897/09-067.1.
  • Lutterbeck, C. A.; Wilde, M. L.; Baginska, E.; Leder, C.; Machado, Ê. L.; Kümmerer, K. Degradation of Cyclophosphamide and 5-Fluorouracil by UV and Simulated Sunlight Treatments: Assessment of the Enhancement of the Biodegradability and Toxicity. Environ. Pollut. 2016, 208, 467–476.
  • González-González, R. B.; Sharma, P.; Singh, S. P.; Américo-Pinheiro, J. H. P.; Parra-Saldívar, R.; Bilal, M.; Iqbal, H. M. N. Persistence, Environmental Hazards, and Mitigation of Pharmaceutically Active Residual Contaminants from Water Matrices. Sci. Total Environ. 2022, 821, 153329.
  • Yin, J.; Shao, B.; Zhang, J.; Li, K. A Preliminary Study on the Occurrence of Cytostatic Drugs in Hospital Effluents in Beijing, China. Bull. Environ. Contam. Toxicol. 2010, 84, 39–45. DOI: 10.1007/s00128-009-9884-4.
  • Novak, M.; Žegura, B.; Modic, B.; Heath, E.; Filipič, M. Cytotoxicity and Genotoxicity of Anticancer Drug Residues and Their Mixtures in Experimental Model with Zebrafish Liver Cells. Sci. Total. Environ. 2017, 601-602, 293–300. DOI: 10.1016/j.scitotenv.2017.05.115.
  • Cristóvão, M. B.; Torrejais, J.; Janssens, R.; Luis, P.; Bruggen, B.; Van der; Dubey, K. K.; Mandal, M. K.; Bronze, M. R.; Crespo, J. G.; Pereira, V. J. Treatment of Anticancer Drugs in Hospital and Wastewater Effluents Using Nanofiltration. Sep. Purif. Technol. 2019, 224, 273–280. DOI: 10.1016/j.seppur.2019.05.016.
  • Besse, J.; Latour, J.; Garric, J. Anticancer Drugs in Surface Waters. What Can we Say about the Occurrence and Environmental Significance of Cytotoxic, Cytostatic and Endocrine Therapy Drugs? Environ. Int. 2012, 39, 73–86.
  • Kümmerer, K.; Al-Ahmad, A. Estimation of the Cancer Risk to Humans Resulting from the Presence of Cyclophosphamide and Ifosfamide in Surface Water. Environ. Sci. Pollut. Res. Int. 2010, 17, 486–496.
  • Negreira, N.; Regueiro, J.; López de Alda, M.; Barceló, D. Degradation of the Anticancer Drug Erlotinib during Water Chlorination: Non-Targeted Approach for the Identification of Transformation Products. Water Res. 2015, 85, 103–113. DOI: 10.1016/j.watres.2015.08.005.
  • Mišík, M.; Filipic, M.; Nersesyan, A.; Kundi, M.; Isidori, M.; Knasmueller, S. Environmental Risk Assessment of Widely Used Anticancer Drugs (5-Fluorouracil, Cisplatin, Etoposide, Imatinib Mesylate). Water Res. 2019, 164, 114953. DOI: 10.1016/j.watres.2019.114953.
  • Jelić, A.; Gros, M.; Petrović, M.; Ginebreda, A.; Barceló, D. Occurrence and Elimination of Pharmaceuticals During Conventional Wastewater Treatment. In Emerging and Priority Pollutants in Rivers; Guasch, H., Ginebreda, A., Geiszinger, A., Eds. Springer Berlin Heidelberg: Berlin, Heidelberg, 2012; Vol. 19, 147–179
  • Ghafuri, Y.; Yunesian, M.; Nabizadeh, R.; Mesdaghinia, A.; Dehghani, M. H.; Alimohammadi, M. Platinum Cytotoxic Drugs in the Municipal Wastewater and Drinking Water, a Validation Method and Health Risk Assessment. Hum. Ecol. Risk Assess. An Int. J. 2018, 24, 784–796. DOI: 10.1080/10807039.2017.1400372.
  • Yin, J.; Yang, Y.; Li, K.; Zhang, J.; Shao, B. Analysis of Anticancer Drugs in Sewage Water By Selective SPE and UPLC-ESI-MS-MS. J. Chromatogr. Sci. 2010, 48, 781–789.
  • Ferrando-Climent, L.; Rodriguez-Mozaz, S.; Barceló, D. Incidence of Anticancer Drugs in an Aquatic Urban System: From Hospital Effluents through Urban Wastewater to Natural Environment. Environ. Pollut. 2014, 193, 216–223. DOI: 10.1016/j.envpol.2014.07.002.
  • Souza, D. M.; Reichert, J. F.; Martins, A. F. A Simultaneous Determination of anti-Cancer Drugs in Hospital Effluent by DLLME HPLC-FLD, Together with a Risk Assessment. Chemosphere. 2018, 201, 178–188. DOI: 10.1016/j.chemosphere.2018.02.164.
  • Gouveia, T. I. A.; Silva, A. M. T.; Ribeiro, A. R.; Alves, A.; Santos, M. S. F. Liquid-Liquid Extraction as a Simple Tool to Quickly Quantify Fourteen Cytostatics in Urban Wastewaters and Access Their Impact in Aquatic Biota. Sci. Total Environ. 2020, 740, 139995. DOI: 10.1016/j.scitotenv.2020.139995.
  • Olalla, A.; Negreira, N.; López de Alda, M.; Barceló, D.; Valcárcel, Y. A Case Study to Identify Priority Cytostatic Contaminants in Hospital Effluents. Chemosphere. 2018, 190, 417–430. DOI: 10.1016/j.chemosphere.2017.09.129.
  • Klein, MdO.; Serrano, S. V.; Santos-Neto, Á.; Cruz, C. d.; Brunetti, I. A.; Lebre, D.; Gimenez, M. P.; Reis, R. M.; Silveira, H. C. S. Detection of anti-Cancer Drugs and Metabolites in the Effluents from a Large Brazilian Cancer Hospital and an Evaluation of Ecotoxicology. Environ. Pollut. 2021, 268, 115857. DOI: 10.1016/j.envpol.2020.115857.
  • Verlicchi, P. Trends, New Insights and Perspectives in the Treatment of Hospital Effluents. Curr. Opin. Environ. Sci. Heal. 2021, 19, 100217. DOI: 10.1016/j.coesh.2020.10.005.
  • Ferrer-Polonio, E.; Fernández-Navarro, J.; Iborra-Clar, M.-I.; Alcaina-Miranda, M.-I.; Mendoza-Roca, J. A. Removal of Pharmaceutical Compounds Commonly-Found in Wastewater through a Hybrid Biological and Adsorption Process. J. Environ. Manage. 2020, 263, 110368.
  • Nielsen, U.; Hastrup, C.; Klausen, M. M.; Pedersen, B. M.; Kristensen, G. H.; Jansen, J. L. C.; Bak, S. N.; Tuerk, J. Removal of APIs and Bacteria from Hospital Wastewater by MBR plus O3, O3 + H2O2, PAC or ClO2. Water Sci. Technol. 2013, 67, 854–862. DOI: 10.2166/wst.2012.645.
  • Cristóvão, M. B.; Bernardo, J.; Bento-Silva, A.; Ressureição, M.; Bronze, M. R.; Crespo, J. G.; Pereira, V. J. Treatment of Anticancer Drugs in a Real Wastewater Effluent Using Nanofiltration: A Pilot Scale Study. Sep. Purif. Technol. 2022, 288, 120565. DOI: 10.1016/j.seppur.2022.120565.
  • Leyva-Díaz, J. C.; Batlles-delaFuente, A.; Molina-Moreno, V.; Sánchez Molina, J.; Belmonte-Ureña, L. J. Removal of Pharmaceuticals from Wastewater: Analysis of the Past and Present Global Research Activities. Water. 2021, 13, 2353. DOI: 10.3390/w13172353.
  • Della-Flora, A.; Wilde, M. L.; Thue, P. S.; Lima, D.; Lima, E. C.; Sirtori, C. Combination of Solar photo-Fenton and Adsorption Process for Removal of the Anticancer Drug Flutamide and Its Transformation Products from Hospital Wastewater. J. Hazard Mater. 2020, 396, 122699.
  • Ferre-Aracil, J.; Valcárcel, Y.; Negreira, N.; Alda, M. d.; Barceló, D.; Cardona, S. C.; Navarro-Laboulais, J. Ozonation of Hospital Raw Wastewaters for Cytostatic Compounds Removal. Kinetic Modelling and Economic Assessment of the Process. Sci. Total Environ. 2016, 556, 70–79.
  • Garcia-Ac, A.; Broséus, R.; Vincent, S.; Barbeau, B.; Prévost, M.; Sauvé, S. Oxidation Kinetics of Cyclophosphamide and Methotrexate by Ozone in Drinking Water. Chemosphere. 2010, 79, 1056–1063. DOI: 10.1016/j.chemosphere.2010.03.032.
  • Kovalova, L.; Siegrist, H.; Gunten, U. v.; Eugster, J.; Hagenbuch, M.; Wittmer, A.; Moser, R.; McArdell, C. S. Elimination of Micropollutants during Post-Treatment of Hospital Wastewater with Powdered Activated Carbon, Ozone, and UV. Environ. Sci. Technol. 2013, 47, 7899–7908.
  • Wols, B. A.; Hofman-Caris, C. H. M.; Harmsen, D. J. H.; Beerendonk, E. F. Degradation of 40 Selected Pharmaceuticals by UV/H2O2. Water Res. 2013, 47, 5876–5888.
  • Bahrpeyma, S.; Hemmateenejad, B.; Javidnia, K. Photo-Degradation Study of Dacarbazine by Spectrophotometric–Chemometrics and HPLC Methods. J. Iran Chem. SOC. 2016, 13, 221–229. DOI: 10.1007/s13738-015-0729-2.
  • Gosetti, F.; Belay, M. H.; Marengo, E.; Robotti, E. Development and Validation of a UHPLC-MS/MS Method for the Identification of Irinotecan Photodegradation Products in Water Samples. Environ. Pollut. 2020, 256, 113370.
  • Somensi, C. A.; Simionatto, E. L.; Dalmarco, J. B.; Gaspareto, P.; Radetski, C. M. A Comparison between Ozonolysis and Sonolysis/Ozonolysis Treatments for the Degradation of the Cytostatic Drugs Methotrexate and Doxorubicin: Kinetic and Efficiency Approaches. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng. 2012, 47, 1543–1550. DOI: 10.1080/10934529.2012.680414.
  • Česen, M.; Kosjek, T.; Laimou-Geraniou, M.; Kompare, B.; Širok, B.; Lambropolou, D.; Heath, E. Occurrence of Cyclophosphamide and Ifosfamide in Aqueous Environment and Their Removal by Biological and Abiotic Wastewater Treatment Processes. Sci. Total Environ. 2015, 527–528, 465–473. DOI: 10.1016/j.scitotenv.2015.04.109.
  • Dodd, M. C.; Zuleeg, S.; Gunten, U. v.; Pronk, W. Ozonation of Source-Separated Urine for Resource Recovery and Waste Minimization: Process Modeling, Reaction Chemistry, and Operational Considerations. Environ. Sci. Technol. 2008, 42, 9329–9337. DOI: 10.1021/es800560r.
  • Escher, B. I.; Pronk, W.; Suter, M. J.-F.; Maurer, M. Monitoring the Removal Efficiency of Pharmaceuticals and Hormones in Different Treatment Processes of Source-Separated Urine with Bioassays. Environ. Sci. Technol. 2006, 40, 5095–5101. DOI: 10.1021/es060598w.
  • Hernández, C.; Ramos, Y.; Fernández, L. A.; Ledea, O.; Bataller, M.; Véliz, E.; Besada, V.; Rosado, A. Ozonation of Cisplatin in Aqueous Solution at pH 9. Ozone Sci. Eng. 2008, 30, 189–196. DOI: 10.1080/01919510801907722.
  • Bolton, J. R.; Stefan, M. I. Fundamental Photochemical Approach to the Concepts of Fluence (UV Dose) and Electrical Energy Efficiency in Photochemical Degradation Reactions. Res. Chem. Intermed. 2002, 28, 857–870. DOI: 10.1163/15685670260469474.
  • Buerge, I. J.; Buser, H.-R.; Poiger, T.; Müller, M. D. Occurrence and Fate of the Cytostatic Drugs Cyclophosphamide and Ifosfamide in Wastewater and Surface Waters †. Environ. Sci. Technol. 2006, 40, 7242–7250. DOI: 10.1021/es0609405.
  • Lai, W. W.-P.; Lin, H. H.-H.; Lin, A. Y.-C. TiO2 Photocatalytic Degradation and Transformation of Oxazaphosphorine Drugs in an Aqueous Environment. J. Hazard. Mater. 2015, 287, 133–141. DOI: 10.1016/j.jhazmat.2015.01.045.
  • Ocampo-Pérez, R.; Sánchez-Polo, M.; Rivera-Utrilla, J.; Leyva-Ramos, R. Degradation of Antineoplastic Cytarabine in Aqueous Phase by Advanced Oxidation Processes Based on Ultraviolet Radiation. Chem. Eng. J. 2010, 165, 581–588. DOI: 10.1016/j.cej.2010.09.076.
  • Nawara, K.; Krysinski, P.; Blanchard, G. J. Photoinduced Reactivity of Doxorubicin: Catalysis and Degradation. J. Phys. Chem. A. 2012, 116, 4330–4337. DOI: 10.1021/jp303218r.
  • Guo, R.; Zheng, F.; Chen, J. Evaluation of the Aquatic Toxic Effect Varied during the Degradation of Capecitabine under the Environmental Abiotic and Biotic Processes. RSC Adv. 2015, 5, 76772–76778. DOI: 10.1039/C5RA17315A.
  • Negreira, N.; Alda, M. d.; Barceló, D. Cytostatic Drugs and Metabolites in Municipal and Hospital Wastewaters in Spain: Filtration, Occurrence, and Environmental Risk. Sci. Total Environ. 2014, 497–498, 68–77. DOI: 10.1016/j.scitotenv.2014.07.101.
  • Carlson, J. C.; Stefan, M. I.; Parnis, J. M.; Metcalfe, C. D. Direct UV Photolysis of Selected Pharmaceuticals, Personal Care Products and Endocrine Disruptors in Aqueous Solution. Water Res. 2015, 84, 350–361.
  • Tripathi, A. K.; David, A.; Govil, T.; Rauniyar, S.; Rathinam, N. K.; Goh, K. M.; Sani, R. K. Environmental Remediation of Antineoplastic Drugs: Present Status, Challenges, and Future Directions. Processes. 2020, 8, 747. DOI: 10.3390/pr8070747.
  • Franquet-Griell, H.; Medina, A.; Sans, C.; Lacorte, S. Biological and Photochemical Degradation of Cytostatic Drugs under Laboratory Conditions. J. Hazard Mater. 2017, 323, 319–328.
  • Calza, P.; Medana, C.; Sarro, M.; Rosato, V.; Aigotti, R.; Baiocchi, C.; Minero, C. Photocatalytic Degradation of Selected Anticancer Drugs and Identification of Their Transformation Products in Water by Liquid Chromatography–High Resolution Mass Spectrometry. J. Chromatogr A. 2014, 1362, 135–144. DOI: 10.1016/j.chroma.2014.08.035.
  • Gunten, U. v Ozonation of Drinking Water: Part I. Oxidation Kinetics and Product Formation. Water Res. 2003, 37, 1443–1467.
  • Garcia-Costa, A. L.; Gouveia, T. I. A.; Pereira, M. F. R.; Silva, A. M. T.; Alves, A.; Madeira, L. M.; Santos, M. S. F. Ozonation of Cytostatic Drugs in Aqueous Phase. Sci. Total Environ. 2021, 795, 148855.

References

  • FRÉDÉRIC, O.; YVES, P. Pharmaceuticals in hospital wastewater: Their ecotoxicity and contribution to the environmental hazard of the effluent. Chemosphere, v. 115, p. 31–39, 2014.
  • GÓMEZ-CANELA, C. et al. Occurrence of cytostatic compounds in hospital effluents and wastewaters, determined by liquid chromatography coupled to high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry, v. 406, n. 16, p. 3801–3814, 14 jun. 2014.
  • RABII, F. W. et al. Determination of six chemotherapeutic agents in municipal wastewater using online solid-phase extraction coupled to liquid chromatography-tandem mass spectrometry. Science of The Total Environment, v. 487, n. 1, p. 792–800, jul. 2014.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.